You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Antibiotic susceptibility of K. pneumoniae

From: Nosocomial outbreak of KPC-2- and NDM-1-producing Klebsiella pneumoniae in a neonatal ward: a retrospective study

Minimal inhibitory concentration (ug/ml)
Antibiotics K. pneumoniaeST11 (n = 25) NDM-1positiveK.pneumoniae (n = 7)
  range range
AMP ≥512 ≥512
CAZ ≥512 ≥512
CTX 128- > 512 64- > 512
FOX 64–256 64–256
FEP 64–256 16–64
CXM ≥512 ≥512
ATM ≥512 1–2
GN 64–256 0.25–0.5
LEV 32–128 0.06–0.25
AK ≥512 1–2
CIP ≥32 0.06–1
TZP 64/4- > 256/4 128/4- > 256/4
SXT 1/19–2/38 ≥256/4864
IPM 8–64 1–16
MEM 4–32 1–32
TGC 0.06–0.5 0.06–0.5
CO 0.03–0.5 0.06–0.25
  1. AMP ampicillin (0.06–512), CAZ ceftazidime (0.06–512), CTX cefotaxime (0.06–512), FEP cefepime (0.06–512), CXM cefuroxime (0.06–512), FOX cefoxitin (0.06–512), GN gentamicin (0.06–512), LEV levofloxacin (0.06–512), AK amikacin (0.06–512), CIP ciprofloxacin (0.004-32), ATM Aztreonam (0.06–512), IPM imipenem (0.03–256), MEM meropenem (0.03–256), TZP piperacillin-tazobactam (0.25/4–256/4), SXT trimethoprim-sulfamethoxazole (0.25/4.75–256/4864), TGC tigecycline (0.03–256), CO colistin (0.03–256)